OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells
Sharon Manley, Appolinaire A. Olou, Jarrid Jack, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 18
Sharon Manley, Appolinaire A. Olou, Jarrid Jack, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 18
Showing 18 citing articles:
C−F bond activation enables synthesis of aryl difluoromethyl bicyclopentanes as benzophenone-type bioisosteres
Mingshuo Chen, Yuang Cui, Xiaoping Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Mingshuo Chen, Yuang Cui, Xiaoping Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 11
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 11
AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review
Sandra Maria Barbalho, Nahúm Méndez‐Sánchez, Lucas Fornari Laurindo
Biochemical Pharmacology (2023) Vol. 218, pp. 115871-115871
Closed Access | Times Cited: 16
Sandra Maria Barbalho, Nahúm Méndez‐Sánchez, Lucas Fornari Laurindo
Biochemical Pharmacology (2023) Vol. 218, pp. 115871-115871
Closed Access | Times Cited: 16
Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer
Ryan Walsh, Joseph Ambrose, Jarrid Jack, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010057-e010057
Open Access
Ryan Walsh, Joseph Ambrose, Jarrid Jack, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010057-e010057
Open Access
Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth
Bailey A. Bye, Jarrid Jack, Alexandra Pierce, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1152-1152
Open Access
Bailey A. Bye, Jarrid Jack, Alexandra Pierce, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1152-1152
Open Access
Bone Marrow Adipocytes in Cancer: Mechanisms, Models, and Therapeutic Implications
Agathe Bessot, Jennifer H. Gunter, Jacqui McGovern, et al.
Biomaterials (2025), pp. 123341-123341
Closed Access
Agathe Bessot, Jennifer H. Gunter, Jacqui McGovern, et al.
Biomaterials (2025), pp. 123341-123341
Closed Access
Exploring the logic and conducting a comprehensive evaluation of AdipoRon-based adiponectin replacement therapy against hormone-related cancers—a systematic review
Lucas Fornari Laurindo, Andreline Franchi Sosin, Caroline Barbalho Lamas, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 2067-2082
Open Access | Times Cited: 7
Lucas Fornari Laurindo, Andreline Franchi Sosin, Caroline Barbalho Lamas, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 2067-2082
Open Access | Times Cited: 7
Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma Growth
Mai Ly Thi Nguyen, Chi Pham, Jeanne Tran Van Nhieu, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 687-695
Closed Access | Times Cited: 2
Mai Ly Thi Nguyen, Chi Pham, Jeanne Tran Van Nhieu, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 687-695
Closed Access | Times Cited: 2
A novel blood-based bioassay to monitor adiponectin signaling
Abdul Hadee Lone, Jialing Tang, Angelica Pignalosa, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111890-111890
Open Access | Times Cited: 2
Abdul Hadee Lone, Jialing Tang, Angelica Pignalosa, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111890-111890
Open Access | Times Cited: 2
Chemically programmed metabolism drives a superior cell fitness for cartilage regeneration
Yi-Shan Chen, Yiyang Yan, Ruonan Tian, et al.
Science Advances (2024) Vol. 10, Iss. 37
Open Access | Times Cited: 2
Yi-Shan Chen, Yiyang Yan, Ruonan Tian, et al.
Science Advances (2024) Vol. 10, Iss. 37
Open Access | Times Cited: 2
C−F Bond Activation Enables Synthesis of Aryl Difluoromethyl Bicyclopentanes as Benzophenone-Type Bioisosteres
Mingshuo Chen, Yuang Cui, Xiaoping Chen, et al.
(2023)
Open Access | Times Cited: 5
Mingshuo Chen, Yuang Cui, Xiaoping Chen, et al.
(2023)
Open Access | Times Cited: 5
Adiponectin Receptor Agonist AdipoRon Inhibits Proliferation and Drives Glycolytic Dependence in Non-Small-Cell Lung Cancer Cells
Sanober Kafeel, Angela Ragone, Alessia Salzillo, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2633-2633
Open Access | Times Cited: 1
Sanober Kafeel, Angela Ragone, Alessia Salzillo, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2633-2633
Open Access | Times Cited: 1
SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1
Appolinaire A. Olou, Joe Ambrose, Jarrid Jack, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 575-590
Open Access | Times Cited: 5
Appolinaire A. Olou, Joe Ambrose, Jarrid Jack, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 575-590
Open Access | Times Cited: 5
AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?
Luigi Sapio, Angela Ragone, Annamaria Spina, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 3, pp. 625-36
Open Access | Times Cited: 4
Luigi Sapio, Angela Ragone, Annamaria Spina, et al.
Cancer Drug Resistance (2022) Vol. 5, Iss. 3, pp. 625-36
Open Access | Times Cited: 4
Autophagy-Related ncRNAs in Pancreatic Cancer
Simone Donati, Cinzia Aurilia, Gaia Palmini, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1547-1547
Open Access | Times Cited: 4
Simone Donati, Cinzia Aurilia, Gaia Palmini, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1547-1547
Open Access | Times Cited: 4
The glycolysis-related AMPK/ULK signaling pathway mediates the inhibitory effect of adiponectin in prostate cancer cells
Simin Yang, Ying Sun, Yifan Guo, et al.
Molecular and Cellular Endocrinology (2024) Vol. 593, pp. 112338-112338
Closed Access
Simin Yang, Ying Sun, Yifan Guo, et al.
Molecular and Cellular Endocrinology (2024) Vol. 593, pp. 112338-112338
Closed Access
Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms
Agnes Bocian, Anna Malczewska, Violetta Rosiek, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3517-3517
Open Access | Times Cited: 1
Agnes Bocian, Anna Malczewska, Violetta Rosiek, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3517-3517
Open Access | Times Cited: 1
Adipose-Tumor Crosstalk contributes to CXCL5 Mediated Immune Evasion in PDAC
Ryan Walsh, Joseph Ambrose, Jarrid Jack, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Ryan Walsh, Joseph Ambrose, Jarrid Jack, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
